Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up Data Support the Curative Potential of Allogeneic Hematopoietic Cell Transplantation in Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis from the Chronic Malignancies Working Party of the EBMT

Blood (2014) 124 (21): 2561.

https://doi.org/10.1182/blood.V124.21.2561.2561

Published: 2014

Journal Articles

Allogeneic HCT with Reduced Intensity Conditioning Versus Autologous HCT for >55 Years Old Patients with Acute Lymphoblastic Leukemia in First Complete Remission: An Analysis from Acute Leukemia Working Party of the EBMT

Sebastian Giebel, Myriam Labopin, MD, Norbert Claude Gorin, MD, Noel Milpied, MD PhD, Eefke Petersen, MDPhD, Michael N Potter, MD PhD, Jan J. Cornelissen, MD PhD, Denis Caillot, MD, Dietger Niederwieser, MD, Rovira Montserrat, Pavel Jindra, MD PhD, Ellen Meijer, MDPhD, Johan Maertens, MD, Alessandro Rambaldi, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2014) 124 (21): 3974.

https://doi.org/10.1182/blood.V124.21.3974.3974

Published: 2014

Journal Articles

High Rates of Passive CMV Antibody Acquisition Pre-Allograft in Patients Receiving Plasma-Rich CMV Unselected and Leukodepleted Blood Components: A Caution for Donor Selection

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Unell Riley, Mark Ethell, MD, Michael N Potter, MD PhD

Blood (2014) 124 (21): 1140.

https://doi.org/10.1182/blood.V124.21.1140.1140

Published: 2014

Journal Articles

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Sebastian Giebel, MD, Myriam Labopin, MD, Adalberto Ibatici, MD, Paul Browne, MD, Tomasz Czerw, Gérard Socié, MD, PhD, Ali Unal, MD, Slawomira Kyrcz-Krzemien, MD, Andrea Bacigalupo, MD, Hakan Goker, MD, Michael N Potter, MBBS, PhD, Grant McQuaker, MD, Dietrich Beelen, MD, Noel Milpied, MD, PhD, Antonio Campos, MD, Charles Craddock, MD DPhil, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2150.

https://doi.org/10.1182/blood.V122.21.2150.2150

Published: 2013

Journal Articles

Donor Attrition At The Confirmatory Typing Stage Results In Poorer Transplant Options For Patients Of All Ethnicities

Robert N Lown, MD, Steven GE Marsh, PhD, Helen Blake, BSc, Irina Evseeva, PhD, Stephen Mackinnon, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Michael N Potter, MBBS, PhD, Nigel H. Russell, MD, Charles Craddock, MD DPhil, J. Alejandro Madrigal, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath

Blood (2013) 122 (21): 3377.

https://doi.org/10.1182/blood.V122.21.3377.3377

Published: 2013

Journal Articles

High Readmission Rates Are Associated with a Significant Economic Burden and Poor Outcome in Patients with Grade 3/4 Acute GvHD

Fiona L Dignan, Michael N Potter, Mark E Ethell, Joy Brennan, Louise McNamara, Stephen O Evans, Claire E. Dearden, Faith E Davies, MD, Gareth J Morgan, MD PhD, Bronwen E. Shaw

Blood (2011) 118 (21): 2061.

https://doi.org/10.1182/blood.V118.21.2061.2061

Published: 2011

Journal Articles

The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia.

Fiona L Dignan, Chloe Anthias, Mark E Ethell, Ricardo Morilla, Alison Morilla, Faith E Davies, MD, Gareth J Morgan, Michael N Potter, Bronwen E Shaw

Blood (2009) 114 (22): 2601.

https://doi.org/10.1182/blood.V114.22.2601.2601

Published: 2009

Journal Articles

A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC.

Bronwen E Shaw, Jane Apperley, Nigel H. Russell, MD, Charles F. Craddock, BM, MRCP, MRCPath, Effie Liakopoulou, Michael N Potter, Robert Wynn, MRCP, FRCPath, MD, Brenda ES Gibson, R. Pearce, Keiren Kirkland, Alejandro Madrigal, Gordon Cook, MD, PhD, Jennifer L Byrne, PhD

Blood (2009) 114 (22): 1205.

https://doi.org/10.1182/blood.V114.22.1205.1205

Published: 2009

Journal Articles

A Single Institution’s Experience with Allogeneic Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia: Analysis of Factors Leading to Improved Outcome

Pawel A Kaczmarek, Michael N Potter, Mark E Ethell, Jennifer G Treleaven, Faith E Davies, Claire E Dearden, Gareth J Morgan, Bronwen E Shaw

Blood (2008) 112 (11): 4322.

https://doi.org/10.1182/blood.V112.11.4322.4322

Published: 2008

Journal Articles

An Early CT-Diagnosis Based Treatment Strategy for Invasive Fungal Infection in Allogeneic Transplant Recipients Using Caspofungin First Line: An Effective Strategy with Low Mortality.

Fiona L Dignan, Stephen O Evans, Mark E Ethell, Bronwen E. Shaw, Unell BG Riley, Faith Davies, Jennifer G. Treleaven, Claire E. Dearden, Gareth J. Morgan, Michael N Potter

Blood (2008) 112 (11): 1149.

https://doi.org/10.1182/blood.V112.11.1149.1149

Published: 2008

Journal Articles

Autologous Transplantation Is the Optimum Approach to the Management of Myeloma Patients with Extramedullary Disease at Presentation

Faith E. Davies, Ping Wu, Kevin Boyd, Radovan Saso, Michael N Potter, Mark E Ethell, Bronwen E Shaw, Jenny Treleaven, Sharon Dines, Gareth J Morgan

Blood (2008) 112 (11): 3313.

https://doi.org/10.1182/blood.V112.11.3313.3313

Published: 2008

Journal Articles

T-Cell Depleted Unrelated Donor Stem Cell Transplants Appear to Be of Value for Adult Philadelphia Chromosome Negative ALL Patients and Should Be Evaluated Prospectively in New Large Group Studies

B. R Patel, Keiren Kirkland, R. Pearce, Richard E Clark, Charles F. Craddock, BM, MRCP, MRCPath, Effie Liakopolou, Adele K Fielding, PhD, Stephen Mackinnon, MD, Eduardo Olavarria, MD, Michael N Potter, Nigel H. Russell, MD, Bronwen E. Shaw, Anthony H. Goldstone, FRCP, FRCPath, David I Marks, MD

Blood (2008) 112 (11): 4413.

https://doi.org/10.1182/blood.V112.11.4413.4413

Published: 2008

NARROW

Long-Term Follow-up Data Support the Curative Potential of Allogeneic Hematopoietic Cell Transplantation in Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis from the Chronic Malignancies Working Party of the EBMT

Allogeneic HCT with Reduced Intensity Conditioning Versus Autologous HCT for >55 Years Old Patients with Acute Lymphoblastic Leukemia in First Complete Remission: An Analysis from Acute Leukemia Working Party of the EBMT

High Rates of Passive CMV Antibody Acquisition Pre-Allograft in Patients Receiving Plasma-Rich CMV Unselected and Leukodepleted Blood Components: A Caution for Donor Selection

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Donor Attrition At The Confirmatory Typing Stage Results In Poorer Transplant Options For Patients Of All Ethnicities

High Readmission Rates Are Associated with a Significant Economic Burden and Poor Outcome in Patients with Grade 3/4 Acute GvHD

The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia.

A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC.

A Single Institution’s Experience with Allogeneic Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia: Analysis of Factors Leading to Improved Outcome

An Early CT-Diagnosis Based Treatment Strategy for Invasive Fungal Infection in Allogeneic Transplant Recipients Using Caspofungin First Line: An Effective Strategy with Low Mortality.

Autologous Transplantation Is the Optimum Approach to the Management of Myeloma Patients with Extramedullary Disease at Presentation

T-Cell Depleted Unrelated Donor Stem Cell Transplants Appear to Be of Value for Adult Philadelphia Chromosome Negative ALL Patients and Should Be Evaluated Prospectively in New Large Group Studies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only